CME Group Inc. $CME Stake Trimmed by Horizon Kinetics Asset Management LLC

Horizon Kinetics Asset Management LLC lowered its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 1.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 279,851 shares of the financial services provider’s stock after selling 3,923 shares during the period. CME Group makes up about 1.0% of Horizon Kinetics Asset Management LLC’s portfolio, making the stock its 15th largest holding. Horizon Kinetics Asset Management LLC owned approximately 0.08% of CME Group worth $73,315,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CME. Bridgewater Advisors Inc. bought a new position in CME Group during the 2nd quarter worth $612,000. Focus Financial Network Inc. acquired a new position in CME Group in the 3rd quarter valued at $1,513,000. The Manufacturers Life Insurance Company bought a new stake in shares of CME Group during the 2nd quarter valued at $53,671,000. Haverford Trust Co bought a new stake in shares of CME Group during the 2nd quarter valued at $13,818,000. Finally, Bowie Capital Management LLC bought a new stake in shares of CME Group during the 2nd quarter valued at $22,991,000. Institutional investors own 87.75% of the company’s stock.

Latest CME Group News

These are some of the CME news items that stood out recently:

  • Positive Sentiment: CME reported that XRP and Micro XRP futures generated $81.2 billion in notional volume across roughly 18 months, averaging $216 million per day through mid-November. Strong activity may support transaction and clearing revenue. Article
  • Positive Sentiment: CME’s latest reported quarter beat analyst expectations: earnings were $3.02 per share versus a $2.99 consensus, while revenue of $1.74 billion exceeded estimates and grew 10.6% year over year. Article
  • Neutral Sentiment: A report highlights exchange operators’ potential exposure to AI-driven trading, but provides no specific new CME business or financial update. Article

Insider Activity at CME Group

In other news, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the completion of the transaction, the insider owned 21,482 shares of the company’s stock, valued at approximately $6,555,232.30. The trade was a 31.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Terrence Duffy sold 27,000 shares of the company’s stock in a transaction on Wednesday, November 18th. The stock was sold at an average price of $309.57, for a total value of $8,358,390.00. Following the sale, the chief executive officer owned 35,442 shares of the company’s stock, valued at approximately $10,971,779.94. This represents a 43.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 61,166 shares of company stock worth $18,276,512 in the last three months. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $307.54 on Friday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock has a market capitalization of $110.08 billion, a price-to-earnings ratio of 25.23, a price-to-earnings-growth ratio of 3.90 and a beta of 0.15. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company’s 50 day simple moving average is $289.43 and its 200 day simple moving average is $282.08.

CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.03. The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the company earned $2.68 earnings per share. As a group, research analysts predict that CME Group Inc. will post 12.36 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s payout ratio is 42.66%.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. UBS Group increased their target price on CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a report on Thursday, October 22nd. Morgan Stanley boosted their price target on CME Group from $337.00 to $359.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. TD Cowen boosted their price target on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, October 5th. Barclays upped their price objective on shares of CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Finally, CLSA set a $367.00 price objective on shares of CME Group in a research note on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, CME Group has a consensus rating of “Hold” and a consensus target price of $314.44.

Get Our Latest Stock Analysis on CME Group

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.